Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.62 |
| ▸ | IL23R | Q5VWK5 | 3/20 | 0.54 |
| ▸ | KISS1R | Q969F8 | 3/20 | 0.54 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.52 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.52 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.52 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.52 |
| ▸ | GLP1R | P43220 | 1/20 | 0.52 |
| ▸ | GCGR | P47871 | 1/20 | 0.52 |
| ▸ | GIPR | P48546 | 1/20 | 0.52 |
| ▸ | NPY4R | P50391 | 3/20 | 0.51 |
| ▸ | NPY1R | P25929 | 2/20 | 0.51 |
| ▸ | NPY2R | P49146 | 2/20 | 0.51 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.51 |
| ▸ | VIPR1 | P32241 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30537833 | 0.93 | TFPI (0.61) | TFPIIL23RKISS1RKEAP1OPRM1 | |
| SCHEMBL30537834 | 0.93 | TFPI (0.60) | TFPIIL23RKISS1RKEAP1OPRM1 | |
| SCHEMBL30537835 | 0.92 | NPY4R (0.60) | TFPIKISS1ROPRM1OPRD1OPRK1 | |
| SCHEMBL16508471 | 0.90 | TFPI (0.57) | TFPIIL23RKISS1RKEAP1OPRM1 | |
| SCHEMBL16508439 | 0.89 | KISS1R (0.55) | TFPIKISS1RKEAP1OPRM1OPRD1 | |
| SCHEMBL16508068 | 0.87 | NPY4R (0.61) | TFPIIL23RKISS1RNPY4RNPY1R | |
| SCHEMBL16508070 | 0.87 | NPY4R (0.61) | TFPIIL23RKISS1RNPY4RNPY1R | |
| SCHEMBL16508093 | 0.86 | TFPI (0.63) | TFPIIL23RKISS1RKEAP1GLP1R | |
| SCHEMBL26057848 | 0.85 | TFPI (0.56) | TFPIIL23RKISS1RKEAP1NPY4R | |
| SCHEMBL16507949 | 0.85 | NPY4R (0.65) | TFPIIL23RNPY4RNPY1RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4233917-A1 | ANTI-INFECTIVE CONJUGATE FOR USE IN THE TREATMENT OF ZIKA VIRUS INFECTION | Universitat Pompeu Fabra (ES) | 2023-08-30 | — | — | EP | disclosed |